BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9242374)

  • 1. Rb interacts with TAF(II)250/TFIID through multiple domains.
    Shao Z; Siegert JL; Ruppert S; Robbins PD
    Oncogene; 1997 Jul; 15(4):385-92. PubMed ID: 9242374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
    Pearson A; Greenblatt J
    Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure, biochemical and genetic characterization of yeast and E. cuniculi TAF(II)5 N-terminal domain: implications for TFIID assembly.
    Romier C; James N; Birck C; Cavarelli J; Vivarès C; Collart MA; Moras D
    J Mol Biol; 2007 May; 368(5):1292-306. PubMed ID: 17397863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
    Adnane J; Shao Z; Robbins PD
    Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.
    Wieczorek E; Brand M; Jacq X; Tora L
    Nature; 1998 May; 393(6681):187-91. PubMed ID: 9603525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics and transcription analysis of human TFIID.
    Purrello M; Di Pietro C; Viola A; Rapisarda A; Stevens S; Guermah M; Tao Y; Bonaiuto C; Arcidiacono A; Messina A; Sichel G; Grzeschik KH; Roeder R
    Oncogene; 1998 Mar; 16(12):1633-8. PubMed ID: 9569032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a domain within human TAF(I)48, a subunit of Selectivity Factor 1, that interacts with helix 2 of TBP.
    Xu S; Hori RT
    Gene; 2004 Sep; 338(2):177-86. PubMed ID: 15315821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor TFIID recruits factor CPSF for formation of 3' end of mRNA.
    Dantonel JC; Murthy KG; Manley JL; Tora L
    Nature; 1997 Sep; 389(6649):399-402. PubMed ID: 9311784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant roles for the TFIID and SAGA complexes in global transcription.
    Lee TI; Causton HC; Holstege FC; Shen WC; Hannett N; Jennings EG; Winston F; Green MR; Young RA
    Nature; 2000 Jun; 405(6787):701-4. PubMed ID: 10864329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histone fold TAF octamer within the yeast TFIID transcriptional coactivator.
    Selleck W; Howley R; Fang Q; Podolny V; Fried MG; Buratowski S; Tan S
    Nat Struct Biol; 2001 Aug; 8(8):695-700. PubMed ID: 11473260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding.
    Fan S; Yuan R; Ma YX; Xiong J; Meng Q; Erdos M; Zhao JN; Goldberg ID; Pestell RG; Rosen EM
    Oncogene; 2001 Aug; 20(35):4827-41. PubMed ID: 11521194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
    Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
    Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
    Hagemeier C; Bannister AJ; Cook A; Kouzarides T
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1580-4. PubMed ID: 8434021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
    Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
    Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
    Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.